(Press-News.org) Charlottesville, VA (February 7, 2012). Researchers at Virginia Commonwealth University Medical Center's VCU Massey Cancer Center and Harold F. Young Neurosurgical Center (Richmond, VA) and Old Dominion University (Norfolk, VA) have discovered that suppression of Wilms tumor 1 protein (WT1) results in downregulation of CD97 gene expression in three glioblastoma cell lines and reduces the characteristic invasiveness exhibited by glial tumor cells. This finding is announced in the article, "Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness," by Archana Chidambaram, Ph.D., and colleagues, published online ahead of print today in the Journal of Neurosurgery. Although further studies must be performed, the authors propose that CD97 may prove to be a new target for anti-glioma therapies.
According to William C. Broaddus, M.D., Ph.D., neurosurgeon and leader of the research team, "the invasive behavior of glioma cells is a key feature of their malignancy in the first place, and more recently there is evidence that treatment of gliomas with anti-angiogenic approaches such as bevacizumab (Avastin) may stimulate the invasive behavior of some gliomas. This may even serve as the mechanism by which these tumors fail to respond to bevacizumab treatment. That means that treatments to attack the invasiveness of gliomas by attacking CD97 expression may have special promise as a new treatment strategy."
WT1 is a transcription factor involved in the normal development of several tissue types. Usually expression of this protein is switched off when tissue reaches the normal adult stage. However, WT1 expression has been identified in numerous malignant diseases—leukemia, lung and breast cancers, sarcomas, reproductive organ tumors, and gliomas to name a few. In fact, the same team of researchers previously documented WT1 expression in 80% of glioma cells and tumor specimens. Because WT1 expression in tumor cells has been shown to play a role in resistance to radiation and chemotherapy as well as promotion of cell proliferation, invasion, and/or angiogenesis, Dr. Broaddus brought together the team to investigate what genes present in malignant gliomas could be mediated by WT1 to confer the virulence displayed by this particular tumor. According to the authors, "given its structural identity…and functional history, it seemed logical that WT1 might regulate the transcription (or posttranscriptional expression) of other genes."
To this end, the research team set out to silence WT1 gene expression in malignant glioma cells and observe the effects of this silencing on other genes in these cells. The researchers did this by using short interfering RNA (siRNA) directed against WT1 in three glioblastoma cell lines: U251-MG, U1242-MG, and GBM-6.
Application of siRNA consistently suppressed WT1 gene expression levels, which in turn produced a significant reduction in cellular invasiveness. A microarray analysis identified other genes that were affected by WT1 silencing. These included 27 genes that were significantly downregulated and 11 that were significantly upregulated. The authors point out that nine of the 27 downregulated genes have putative or established roles in oncogenesis, and seven of the 11 upregulated genes have putative or established roles in tumor suppression. All but one gene demonstrating dysregulation during WT1 silencing have at least one potential binding site for WT1 in their promoter regions; the other gene (PDGF-D) has binding sites for Egr1, which recognizes and binds consensus binding sequences shared by WT1.
Prior to this study, there were no reports of CD97 overexpression in glioma cells. It was therefore surprising to the research team that the CD97 gene consistently displayed a direct correlation with WT1 in all three glioblastoma cell lines. Given CD97's putative role in aiding cell invasiveness and neoangiogenesis in other non-brain tumors, the decision was made to examine this cell-surface receptor specifically.
CD97 belongs to the adhesion G-protein–coupled receptor family. Western blot analysis demonstrated overexpression of CD97 protein in the three cell lines. Quantitative reverse transcriptase¬–polymerase chain reaction showed a six- to 21-fold increase in CD97 expression in the tumor cells over that found in normal human astrocytes, which displayed minimal CD97 expression. After siRNA transfection methods were applied to silence the CD97 gene, CD97 mRNA levels lowered significantly: approximately 50% in U251-MG cells, nearly 80% in GBM-6 cells, and 20% in U1242-MG cells. To examine whether these results would impact the glioblastoma cells' invasive capabilities, the researchers plated cells on Matrigel-coated filters of Transwell plates to see whether the cells would invade the Matrigel. In each cell type the cellular invasiveness potential decreased: to 54% of control (tumor cells) in U251-MG cells, approximately 50% of control in GBM-6 cells, and 26% of control in U1242-MG cells.
Perhaps the greatest challenge faced in treating malignant gliomas is their strong invasive capacity. The authors believe their data indicate that upregulation of CD97 mediated by WT1 possibly promotes this invasiveness. The findings of this study show a definite relationship between CD97 overexpression and the invasive quality of malignant glioma cells, which is correlated to the relationship between WT1 expression and the invasive characteristic of glioma cells—relationships that in the future may be exploited in a therapeutic setting.
###
Chidambaram A, Fillmore HL, Van Meter TE, Dumur CI, Broaddus WC. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness. Laboratory investigation. Journal of Neurosurgery, published ahead of print February 7, 2012; DOI: 10.3171/2011.11.JNS111455.
Disclosure: The research presented in this paper was supported in part by the F. Norton Hord, Jr. Fund of the Medical College of Virginia Foundation and the Department of Neurosurgery, Virginia Commonwealth University. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
For additional information, contact:
Ms. Gillian Shasby, Director of Publications–Operations
Journal of Neurosurgery Publishing Group
1224 Jefferson Park Avenue, Suite 450
Charlottesville, VA 22903
Email: gshasby@thejns.org
Telephone 434-924-5555
Fax 434-924-5782
For well over 60 years, the Journal of Neurosurgery has been recognized by neurosurgeons and other medical specialists the world over for its authoritative, clinical articles, cutting-edge laboratory research papers, renowned case reports, expert technical notes, and more. Each article is rigorously peer reviewed. The Journal of Neurosurgery is published monthly by the JNS Publishing Group, the scholarly journal division of the American Association of Neurological Surgeons (http://www.aans.org), an association dedicated to advancing the specialty of neurological surgery in order to promote the highest quality of patient care. The Journal of Neurosurgery appears in print and on the Internet (http://www.thejns.org).
END
Cleveland -- The use of padded headgear and gloves reduces the impact that fighters absorb from hits to the head, according to newly published research from Cleveland Clinic.
In their biomechanics lab at Cleveland Clinic's Lutheran Hospital, the researchers replicated hook punches to the head using a crash test dummy and a pendulum. The impacts were measured under five padding configurations: without headgear or boxing gloves; with headgear and boxing gloves; with headgear but without boxing gloves; with boxing gloves but without headgear; and with mixed martial arts-style ...
Counties and parishes with a greater concentration of small, locally-owned businesses have healthier populations — with lower rates of mortality, obesity and diabetes — than do those that rely on large companies with "absentee" owners, according to a national study by sociologists at LSU and Baylor University.
"What stands out about this research is that we often think of the economic benefits and job growth that small business generates, but we don't think of the social benefits to small communities," said Troy C. Blanchard, Ph.D., lead author and associate professor ...
TUSCALOOSA, Ala. — Treatments for Parkinson's disease, estimated to affect 1 million Americans, have yet to prove effective in slowing the progression of the debilitating disease.
However, University of Alabama researchers have identified how a specific gene protects dopamine-producing neurons from dying in both animal models and in cultures of human neurons, according to a scientific article publishing in the Feb. 8 edition of The Journal of Neuroscience.
This increased understanding of the gene's neuro-protective capability is, the researchers said, another step toward ...
Foam forming technology gives exciting opportunities to develop new recyclable and light weight wood fiber products. It also gives a possibility to decrease raw material and production costs remarkably compared to recent technology. VTT Technical Research Centre of Finland, together with industry has started setting up a new pilot scale technology platform for foam forming applications.
With foam forming technology it is possible to improve paper properties and enable to manufacture high porosity, smooth and light weight products (e.g. hygiene products, insulation materials ...
Philadelphia, PA, February 7, 2012 – With no lab tests to guide the clinician, psychiatric diagnostics is challenging and controversial. Antisocial personality disorder is defined as "a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood," according to the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) of the American Psychiatric Association.
DSM-IV provides formal diagnostic criteria for every psychiatric disorder. This process may be ...
On January 24, 2012, Congress was scheduled to vote on whether to debate two controversial bills regarding Internet privacy and intellectual property. The Protect Intellectual Property Act (PIPA) and the Stop Online Piracy Act (SOPA) were meant to limit online piracy and stem copyright infringement. However, they were met with fervent opposition from civil liberties advocates, privacy groups, online search engines and millions of consumers. Congressional offices were swamped with phone calls, letters and emails calling for legislators not to support the bill.
In fact, ...
The fingers on the outside – i.e. the thumb and little finger - therefore react faster than the middle finger, which is exposed to the "cross fire" of two neighbours on each side. Through targeted learning, this speed handicap can be compensated. The working group led by PD Dr. Hubert Dinse (Neural Plasticity Lab at the Institute for Neuroral Computation) report in the current issue of PNAS.
Thumb and little finger are the quickest
The researchers set subjects a simple task to measure the speed of decision: they showed them an image on a monitor that represented all ...
A green thumb is required where plants are to grow abundantly – that also applies to watering them in dry areas. If they are watered too much, then the soil becomes saline; if the plants receive too little moisture, they let their leaves droop and, in the worst case, they wither. In the future, sensors in the soil, a central unit and an associated app will supplement the green thumb: one look at the smart phone and the farmer will know what moisture content the soil has. Which plants need water, which do not? If the plants get too dry, the farmer is alerted by SMS; the ...
Researchers from North Carolina State University have developed a new technique that allows graphics processing units (GPUs) and central processing units (CPUs) on a single chip to collaborate – boosting processor performance by an average of more than 20 percent.
"Chip manufacturers are now creating processors that have a 'fused architecture,' meaning that they include CPUs and GPUs on a single chip," says Dr. Huiyang Zhou, an associate professor of electrical and computer engineering who co-authored a paper on the research. "This approach decreases manufacturing costs ...
In 2010, Dr. Svante Pääbo and his colleagues presented a draft version of the genome from a small fragment of a human finger bone discovered in Denisova Cave in southern Siberia. The DNA sequences showed that this individual came from a previously unknown group of extinct humans that have become known as Denisovans. Together with their sister group the Neandertals, Denisovans are the closest extinct relatives of currently living humans.
The Leipzig team has now developed sensitive novel techniques which have allowed them to sequence every position in the Denisovan genome ...
